Skip to main content
Clinical Trials/NCT07281287
NCT07281287RecruitingNot Applicable

Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation

University of Alabama at Birmingham1 site in 1 country40 target enrollmentStarted: February 1, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
40
Locations
1
Primary Endpoint
Change in financial hardship

Study Overview

Brief Summary

The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are:

  1. How did oncology financial navigation implementation strategies affect implementation outcomes?
  2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress?
  3. How were implementation strategies utilized to overcome barriers to oncology financial navigation?

Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.

Detailed Description

Guided by the RE-AIM Extension for Equitable Sustainability framework, the investigators will use a series of implementation and effectiveness aims to evaluate equitable implementation of oncology financial navigation into routine cancer care delivery. The investigators hypothesize the proposed assessment will identify potential areas to improve implementation of oncology financial navigation, which will result in better financial and clinical outcomes for patients with cancer. The investigators propose a pragmatic, hybrid effectiveness-implementation study to assess outcomes of oncology financial navigation delivered as routine cancer care and collect information on strategies to address implementation barriers. Outcomes will be assessed overall and for inequities by race, residence, and insurance status using the following specific aims:

Aim 1. Track oncology financial navigation implementation strategies and their effect on implementation outcomes

Aim 2. Evaluate oncology financial navigation effectiveness

Aim 3. Assess how implementation strategies were utilized to overcome barriers to oncology financial navigation

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for:
  • All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic
  • UAB oncology financial navigators

Exclusion Criteria

  • Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include:
  • Patients with cancer seen at the UAB Medical Oncology clinic
  • Patients with non-missing patient-reported outcome data
  • Exclusion criteria: None.
  • Inclusion criteria:
  • Patients who have received oncology financial navigation
  • Providers (oncology financial navigators, social workers, nurse managers, oncologists) involved with the oncology financial navigation program
  • Health system team members (billing specialists, cancer service line leadership) involved with the oncology financial navigation program
  • Exclusion criteria: None.

Arms & Interventions

Patients receiving standard-of-care-delivered financial navigation

Experimental

Intervention: Financial navigation (Behavioral)

Historical control patients who did not receive financial navigation

No Intervention

Outcomes

Primary Outcomes

Change in financial hardship

Time Frame: 6 months post-initiation of systemic therapy

Change in patient-reported financial distress (COmprehensive Score for financial Toxicity)

Change in financial difficulties

Time Frame: 6 months post-initiation of systemic therapy

Change in patient-reported financial difficulties (trouble paying for basic needs, utilities, transportation or lodging for treatment, medications, medical supplies, upfront medical payments, insurance or medical bills, child or eldercare, and employment or disability issues)

Change in quality of life

Time Frame: 6 months post-initiation of systemic therapy

Change in patient-reported quality of life (PROMIS v1.1 Global Health)

Change in psychological distress

Time Frame: 6 months post-initiation of systemic therapy

Change in patient-reported psychological distress (National Comprehensive Cancer Network Distress Thermometer)

Utilization of implementation strategies

Time Frame: Quarterly tracking of strategies with monthly assessment of implementation outcomes, through study completion, an average of 4 years

Track oncology financial navigation implementation strategies using the Expert Recommendations for Implementing Change (ERIC) implementation strategy taxonomy and their effect on implementation outcomes of Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM)

Patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies

Time Frame: Annually through study completion, an average of 4 years

Using qualitative interviews, we will assess patient, provider, and health system perspectives of oncology financial navigation implementation barriers addressed via implementation strategies

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Courtney Williams

Assistant Professor

University of Alabama at Birmingham

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Strong Evidence: Digitally Delivered Exercise in Older Adults
NCT07282951University of California, San Diego60
Completed
Not Applicable
A Study to Assess the Effectiveness of a Marketed Denture Adhesive in Real-World Setting
NCT07273149HALEON375
Recruiting
Phase 2
CO43923 Master Protocol: A Study Evaluating the Safety and Efficacy of Multiple Treatments in Patients with Multiple Myeloma CO43923 Substudy 1: A Study to Collect Patient-Level Data in Patients with Multiple Myeloma CO43923 Substudy 2 Cevos + Len Treatment: A Study Evaluating the Safety and Efficacy of Cevostamab in Combination with Lenalidomide in Patients with Cytogenetic High-Risk Features Receiving Maintenance Treatment After First Response from Multiple Myeloma Post-Stem Cell Transplant CO43923 Substudy 4 Cevostamab+ Iberdomide Treatment: A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cevostamab in Combination with Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
2023-504484-16-00F. Hoffmann-La Roche AG32
Recruiting
Not Applicable
Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students
NCT07266857Centre Hospitalier Universitaire de Nice11,000
Not yet recruiting
Not Applicable
National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients
NCT07268898Institute of Hematology & Blood Diseases Hospital, China500
Evaluating the Implementation and Impact... | Clinical Trial